Bio-batch size for suspensions [Regulatives / Guidelines]

posted by sireen – Jordan, 2015-08-24 07:20 (3961 d 10:52 ago) – Posting: # 15325
Views: 3,196

Dear All,

The emea guideline for bioequivalence, 2010, states that the test product (for oral solid forms) should usually originate from a batch of at least 1/10 of production scale or 100,000 units, whichever is greater, unless otherwise justified.....What about oral suspensions and powder for suspension, packaged in multiple dose containers....what is the requested Bio-batch size?

I'll appreciate if someone could send me any references on this subject.

Many thanks in advance!
Sireen

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
362 visitors (0 registered, 362 guests [including 13 identified bots]).
Forum time: 18:13 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5